PULMONARY FIBROSIS AFTER COVID-19 – RISK FACTORS, MECHANISMS, THERAPEUTIC OPTIONS AND FOLLOW-UP
Journal of IMAB - Annual Proceeding (Scientific Papers) · 14.07.2026 · 32 (3) · 6971-6978
DOI: 10.5272/jimab.2026323.6971 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of IMAB - Annual Proceeding (Scientific Papers), online erschienen am 14.07.2026. Verfasst von Zlatina Ivanova und 2 weiteren Autor:innen.
Abstract (Originalsprache)
The Covid-19 pandemic passed several years ago, but a significant proportion of people still suffer its consequences. Physicians face the difficult task of managing these consequences, monitoring their patients over time, and the need to apply an individual-specific approach. In this article, the main risk factor and mechanisms for developing post-COVID fibrosis are discussed. The available therapeutic options for preventing and treating of that type of fibrosis are summarized. The need for follow-up of these patients is emphasized. Basic guidelines and optimal time intervals for their follow-up are presented.
Zitieren
APA
Ivanova, Z., Kyuchukov, N., & Ivanov, Y. (2026). PULMONARY FIBROSIS AFTER COVID-19 – RISK FACTORS, MECHANISMS, THERAPEUTIC OPTIONS AND FOLLOW-UP. Journal of IMAB - Annual Proceeding (Scientific Papers), 32(3), 6971-6978. https://doi.org/10.5272/jimab.2026323.6971
Vancouver
Ivanova Z, Kyuchukov N, Ivanov Y. PULMONARY FIBROSIS AFTER COVID-19 – RISK FACTORS, MECHANISMS, THERAPEUTIC OPTIONS AND FOLLOW-UP. Journal of IMAB - Annual Proceeding (Scientific Papers). 2026;32(3):6971-6978. doi:10.5272/jimab.2026323.6971
BibTeX
@article{Ivanova2026,
author = {Ivanova, Zlatina and Kyuchukov, Nikolay and Ivanov, Yavor},
title = {PULMONARY FIBROSIS AFTER COVID-19 – RISK FACTORS, MECHANISMS, THERAPEUTIC OPTIONS AND FOLLOW-UP},
journal = {Journal of IMAB - Annual Proceeding (Scientific Papers)},
year = {2026},
volume = {32},
number = {3},
pages = {6971--6978},
doi = {10.5272/jimab.2026323.6971}
}
EUVIMED